Voyager Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio2.817.29
P/S Ratio3.871.495.762.751.56
P/B Ratio1.031.573.991.081.74
Price/Tangible Book1.031.573.991.081.74
Price/FCF4.97
Price/OCF4.76
Enterprise Value Ratios
EV/Revenue0.120.563.120.710.57
EV/EBITDA1.103.12
EV/EBIT1.143.56
EV/FCF1.87
Profitability & Returns
Return on Equity (ROE)-0.24%0.90%-0.60%-0.57%0.29%
Return on Assets (ROA)-0.14%0.30%-0.16%-0.20%0.06%
Return on Invested Capital (ROIC)-1.57%-5.36%
Return on Capital Employed (ROCE)-0.23%0.42%-0.53%-0.52%0.12%
Leverage & Solvency Ratios
Debt/Equity0.150.090.390.470.31
Debt/EBITDA0.161.27
Debt/FCF0.27
Liquidity Ratios
Current Ratio5.564.961.722.687.39
Quick Ratio5.454.891.652.617.07
Efficiency Ratios
Asset Turnover0.210.980.230.160.56
Yield & Distribution Ratios
Earnings Yield-0.21%0.36%-0.20%-0.69%0.14%
FCF Yield-0.06%0.20%-0.06%-0.54%-0.41%
Buyback Yield-0.29%-0.16%-0.02%-0.01%-0.04%